Search Results

87 results were found

Activity Type CME Provider Title Credit Hours Fee End Date
Reset sort order
JAMA Oncology Oral Mucosal Pigmentation in a Patient With Mycosis Fungoides 1 Yes 8/10/2026
JAMA Oncology Neoadjuvant Endocrine Therapy in Clinical Practice - A Review 1 Yes 11/18/2024
JAMA Oncology Neoadjuvant Endocrine Therapy in Clinical Practice 1 Yes 11/18/2024
JAMA Oncology Management of Down Syndrome Associated Leukemias - A Review 1 Yes 7/13/2024
JAMA Oncology Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors - A Systematic Review 1 Yes 1/20/2025
JAMA Oncology Management of Cutaneous Immune-Related Adverse Events in Patients With Cancer Treated With Immune Checkpoint Inhibitors 1 Yes 1/20/2025
JAMA Oncology Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors 1 Yes 4/22/2025
JAMA Oncology Long-term Immunogenicity of BNT162b2 Vaccine in Patients With Solid Tumors 1 Yes 4/22/2025
JAMA Oncology Left Shoulder Fungating Mass in a 46-Year-Old Man 1 Yes 6/15/2026
JAMA Oncology Interstitial Lung Disease Induced by Anti-ERBB2 Antibody-Drug Conjugates 1 Yes 12/16/2024
JAMA Oncology Inhibition of SARS-CoV-2 Omicron BA.1 and BA.4 Variants After Fourth Vaccination or Tixagevimab and Cilgavimab Administration in Patients With Cancer 1 Yes 9/23/2025
JAMA Oncology Incidence of Axillary Adenopathy in Breast Imaging After COVID-19 Vaccination 1 Yes 8/4/2024
JAMA Oncology Immunotherapy in the Treatment of Localized Genitourinary Cancers 1 Yes 8/10/2024
JAMA Oncology Immune Responses to SARS-CoV-2 Among Patients With Cancer - What Can Seropositivity Tell Us? 1 Yes 6/4/2024
JAMA Oncology Identification of Deaths Caused by Cancer and COVID-19 in the US During March to December 2020 1 Yes 10/26/2025
JAMA Oncology Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients 1 Yes 3/18/2025
JAMA Oncology Humoral Responses Against Variants of Concern by COVID-19 mRNA Vaccines in Immunocompromised Patients 1 Yes 3/18/2025
JAMA Oncology Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors 1 Yes 3/17/2025
JAMA Oncology Human Leukocyte Antigen Class I Antigen-Processing Machinery Upregulation by Anticancer Therapies in the Era of Checkpoint Inhibitors 1 Yes 3/17/2025
JAMA Oncology Global Association of COVID-19 Pandemic Measures With Cancer Screening- A Systematic Review and Meta-analysis 1 Yes 8/1/2025